The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A concise starter checklist for beginners to organize money, set goals, and monitor progress month by month.
16,400 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Alibaba shares slid about 7% after quarterly results, underscoring a push into AI and cloud infrastructure. Investors...
A private AI startup is offering a sub-$1 pre-IPO round open to retail investors, pricing shares at $0.66 and promisi...
Brent crude surged to $119, shaking nerves across the markets as energy names led gains while other sectors faced pre...
Markets pivot as inflation remains above target and energy prices climb. One economist warns the next time moves it’l...
A 300-year cross-Atlantic study shows government bonds often lose real value during wars and major emergencies, a pat...
A private transit corridor through Iran’s Hormuz approach is taking shape, redefining energy flows and how households...
U.S. prosecutors in New York investigate links between Colombia's president and drug traffickers, while the DEA desig...
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
A new security study shows post-hack damage outpaces the initial theft. In 2026, projects confront funding cuts, dela...
Bitcoin vaulted past $70,000 in minutes, sending a broad risk-on rally across assets. Analysts warn the move produced...
A big stake in Sotera Health has caught the market's eye as shares slide. This article breaks down what a $175 millio...